Fredrik Kjaer

Fredrik Kjaer is an experienced executive in the pharmaceutical industry, currently serving as Vice President of Commercial Planning & Evaluation and Managing Director for Lundbeck Australia & New Zealand since February 2011. With a strong background in global marketing, Fredrik has led the marketing efforts for significant brands in depression and schizophrenia, managing alliances with major partners such as Otsuka and Takeda. Previous roles include Vice President positions for the schizophrenia and depression portfolios, along with key contributions during crucial product launches, including Lundbeck's first global launch of Brintellix. Fredrik's extensive experience is supported by a Master's Degree in Marketing from Mid Sweden University and participation in advanced programs at IMD and London Business School.